{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:58:52Z","timestamp":1761746332116,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinre.2025.102677","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:11:53Z","timestamp":1756192313000},"page":"102677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiorgan fibrosis in Gaucher disease type I: an unmet goal of enzyme replacement therapy"],"prefix":"10.1016","volume":"49","author":[{"given":"Zufit","family":"Hexner-Erlichman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimer","family":"Assy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayaf","family":"Habashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awni","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2025.102677_bib0001","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher disease in bone: from pathophysiology to practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinre.2025.102677_bib0002","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2025.102677_bib0003","doi-asserted-by":"crossref","first-page":"e0039","DOI":"10.5041\/RMMJ.10173","article-title":"Hemorrhagic aspects of Gaucher disease","volume":"5","author":"Rosenbaum","year":"2014","journal-title":"Rambam Maimonid Med J"},{"key":"10.1016\/j.clinre.2025.102677_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024251","article-title":"Population-based cohort of 500 patients with Gaucher disease in Israel","volume":"9","author":"Jaffe","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinre.2025.102677_bib0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cbpa.2019.10.006","article-title":"Glycosphingolipids and lysosomal storage disorders as illustrated by Gaucher disease","volume":"53","author":"Aerts","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.clinre.2025.102677_bib0006","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease\u2014diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinre.2025.102677_bib0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.clinre.2025.102677_bib0008","first-page":"72","article-title":"Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history","volume":"12","author":"Baris","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.clinre.2025.102677_bib0009","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1615\/CritRevOncog.2013006060","article-title":"Gaucher disease: a comprehensive review","volume":"18","author":"Rosenbloom","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.clinre.2025.102677_bib0010","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.2169\/internalmedicine.1425-22","article-title":"Gaucher disease types I and III responded well to substrate reduction therapy using eliglustat","volume":"62","author":"Harai","year":"2023","journal-title":"Intern Med"},{"key":"10.1016\/j.clinre.2025.102677_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175023","article-title":"Update of treatment for Gaucher disease","volume":"926","author":"Kong","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinre.2025.102677_bib0012","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2025.102677_bib0013","doi-asserted-by":"crossref","first-page":"86","DOI":"10.15403\/jgld-4752","article-title":"Hepatic, splenic, and bone marrow gaucheromas: a case series and systematic literature review","volume":"32","author":"Chis","year":"2023","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0014","article-title":"Natural history of inflammation and impaired autophagy in children with Gaucher disease identified by newborn screening","volume":"42","author":"Gragnaniello","year":"2025","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.clinre.2025.102677_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmhg.2015.02.001","article-title":"Cytokines in Gaucher disease: role in the pathogenesis of bone and pulmonary disease. Egypt","volume":"16","author":"Tantawy","year":"2015","journal-title":"J Med Hum Genet"},{"key":"10.1016\/j.clinre.2025.102677_bib0016","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.blre.2016.05.003","article-title":"Hyperferritinemia and iron metabolism in Gaucher disease: potential pathophysiological implications","volume":"30","author":"Regenboog","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.clinre.2025.102677_bib0017","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1542\/peds.109.6.1170","article-title":"Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy","volume":"109","author":"Perel","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinre.2025.102677_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/bcmd.2001.0480","article-title":"Cholelithiasis in patients with Gaucher disease","volume":"28","author":"Rosenbaum","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0019","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2016.10.001","article-title":"Liver involvement in Gaucher disease\u2014review and clinical approach","volume":"68","author":"Adar","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.dld.2020.01.004","article-title":"Liver involvement in Gaucher disease: a practical review for the hepatologist and the gastroenterologist","volume":"52","author":"Carubbi","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057507","article-title":"Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage","volume":"8","author":"Bohte","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinre.2025.102677_bib0022","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bcmd.2016.06.009","article-title":"Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease","volume":"60","author":"Regenboog","year":"2016","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0023","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s00261-024-04293-w","article-title":"Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease","volume":"49","author":"Parente","year":"2024","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.clinre.2025.102677_bib0024","first-page":"89","article-title":"Noninvasive tests for liver fibrosis in chronic liver disease: recent advances and clinical applications","volume":"29","author":"Kim","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.clinre.2025.102677_bib0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000489251","article-title":"Gaucher disease and myelofibrosis: a combined disease or a misdiagnosis?","volume":"139","author":"Mariani","year":"2018","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clinre.2025.102677_bib0026","first-page":"117","article-title":"Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease","volume":"124","author":"Nascimbeni","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clinre.2025.102677_bib0027","article-title":"Liver involvement in patients with Gaucher disease types I and III","volume":"22","author":"Starosta","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.clinre.2025.102677_bib0028","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.clinre.2025.102677_bib0029","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ymgme.2017.10.013","article-title":"Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients","volume":"123","author":"Serai","year":"2018","journal-title":"Molecul Genet Metabol"},{"key":"10.1016\/j.clinre.2025.102677_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2019.10.013","article-title":"Controlled attenuation parameter and liver stiffness measurements using transient elastography by FibroScan in gaucher disease","volume":"129","author":"Lipi\u0144ski","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clinre.2025.102677_bib0031","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bcmd.2016.12.010","article-title":"Are transient and shear wave elastography useful tools in Gaucher disease?","volume":"68","author":"Webb","year":"2018","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0032","article-title":"Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis","volume":"6","author":"Rigamonti","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.clinre.2025.102677_bib0033","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/cld.1185","article-title":"A primer to the diagnostic and clinical utility of spleen stiffness measurement in patients with chronic liver disease","volume":"19","author":"Mladenovic","year":"2022","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.clinre.2025.102677_bib0034","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcmd.2014.07.007","article-title":"Iron homeostasis and inflammatory biomarker analysis in patients with type 1 Gaucher disease","volume":"53","author":"Medrano-Engay","year":"2014","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcmd.2016.10.010","article-title":"Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1","volume":"68","author":"Lorenz","year":"2018","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.clinre.2025.102677_bib0036","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ymgme.2025.109010","article-title":"Predicting liver fibrosis in Gaucher disease: Investigation of contributors and development of a clinically applicable Gaucher liver fibrosis score","volume":"144","author":"Starosta","year":"2025","journal-title":"Mol Genet Metab"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:35:28Z","timestamp":1759548928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2210740125001548"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102677","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiorgan fibrosis in Gaucher disease type I: an unmet goal of enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102677"}}